PW Medtech Group (FRA:PWE) Common Stock: €0.11 Mil (As of Dec. 2025)


FRA:PWE PW Medtech Group Ltd FRA:PWE
84 GF Score
Price €0.11
GF Value €0.13
! 7 Warning Signs
View Full Analysis

What is PW Medtech Group Common Stock?

PW Medtech Group FRA:PWE 84 Common Stock is €0.11 Mil as of Dec. 2025. GuruFocus rates FRA:PWE with a GF Score™ of 84/100 and a GF Value™ of €0.13. The stock has 7 warning signs investors should review.

PW Medtech Group's quarterly common stock declined from Dec. 2024 (€0.12 Mil) to Jun. 2025 (€0.11 Mil) and declined from Jun. 2025 (€0.11 Mil) to Dec. 2025 (€0.11 Mil).

PW Medtech Group's annual common stock declined from Dec. 2023 (€0.12 Mil) to Dec. 2024 (€0.12 Mil) and declined from Dec. 2024 (€0.12 Mil) to Dec. 2025 (€0.11 Mil).

PW Medtech Group Common Stock Historical Data

* Premium members only.

The historical data trend for PW Medtech Group's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PW Medtech Group Common Stock Chart

PW Medtech Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.13 0.12 0.12 0.11

PW Medtech Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.12 0.12 0.11 0.11
FRA:PWE
84GF Score
PW Medtech Group Ltd FRA:PWE
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PW Medtech Group Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €0.11 Mil mean?
PW Medtech Group (FRA:PWE) has a Common Stock of €0.11 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on PW Medtech Group and its competitors.
Is PW Medtech Group's Common Stock too high?
PW Medtech Group's current Common Stock is €0.11 Mil. Overall, PW Medtech Group has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does PW Medtech Group's Common Stock compare to ISRG and BDX?
PW Medtech Group's Common Stock of €0.11 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on PW Medtech Group and its competitors. PW Medtech Group's current Common Stock is €0.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PW Medtech Group stock overvalued right now?
PW Medtech Group (FRA:PWE) has a current Common Stock of €0.11 Mil. The stock's GF Value™ is €0.13, compared to a current price of €0.11 — trading 18.5% below its estimated fair value. The current Common Stock is €0.11 Mil. PW Medtech Group's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For PW Medtech Group (FRA:PWE), the current Common Stock is €0.11 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PW Medtech Group (FRA:PWE) Overvalued in 2026?

Based on GuruFocus' analysis, PW Medtech Group stock appears to be undervalued. The current stock price of €0.11 is trading 18.5% below its estimated GF Value™ of €0.13.

Key valuation signals for FRA:PWE:

  • Common Stock: €0.11 Mil
  • GF Value™: €0.13 vs. price of €0.11 (18.5% below fair value)
  • GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the FRA:PWE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PW Medtech Group Business Description

Other Exchanges 01358:Hong Kong
Address No. 23 Panlong West Road, Building 1, Pinggu District, Beijing, CHN, 101204
PW Medtech Group Ltd is a medical device company focused on China's medical device industry. The Group operates in infusion sets, blood purification products, and regenerative medical biomaterials. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, insulin needles and pens, high flux and low flux hemodialyzers, hemodiafilters, hemoperfutors, and dialysis machines. Its segments are Infusion Set Business, Blood Purification Business, which represents the R&D, manufacturing, and sales of hemodialysis and blood purification medical devices, and Regenerative Medical Biomaterials Business, which generates maximum revenue. Geographically, it operates in China, North America, India and Others.
84GF Score

Get the complete analysis for FRA:PWE

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.11
Price
€0.13
GF Value